MARSHALL WACE, LLP - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 82 filers reported holding HOMOLOGY MEDICINES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q4 2022$26,176
-45.5%
20,775
-31.2%
0.00%
Q3 2022$48,000
+14.3%
30,175
+40.4%
0.00%
Q2 2022$42,000
-98.6%
21,486
-94.7%
0.00%
-100.0%
Q2 2021$2,953,000
+4242.6%
406,401
+9225.4%
0.01%
+1200.0%
Q1 2020$68,000
+83.8%
4,358
+112.4%
0.00%
Q3 2019$37,000
-87.6%
2,052
-86.5%
0.00%
-100.0%
Q2 2019$298,000
+101.4%
15,241
+185.4%
0.00%
+100.0%
Q1 2019$148,0005,3400.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q3 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$51,211,00017.25%
Vida Ventures Advisors, LLC 770,845$8,703,0001.79%
AAF Wealth Management, LLC 59,790$675,0000.61%
Vivo Capital, LLC 853,143$9,632,0000.43%
Bellevue Group AG 1,737,122$19,612,0000.22%
PREMIER ASSET MANAGEMENT LLC 77,108$871,0000.18%
Temasek Holdings (Private) Ltd 3,220,293$36,357,0000.16%
American Investment Services, Inc. 36,955$417,0000.13%
Virtus ETF Advisers LLC 24,646$278,0000.12%
FIRST MIDWEST BANK TRUST DIVISION 65,983$745,0000.11%
View complete list of HOMOLOGY MEDICINES INC shareholders